Latest immunotherapy Stories
MONMOUTH JUNCTION, N.J., April 24, 2015 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb®
COPENHAGEN, Denmark, April 23, 2015 /PRNewswire/ -- DanDrit Biotech A/S ("DanDrit Denmark"), the subsidiary of DanDrit Biotech USA, Inc.
MAINZ, Germany, April 22, 2015 /PRNewswire/ -- Potential for truly personalized treatment of any cancer BioNTech AG [http://www.biontech.de
National cancer research nonproft raises money to fund cell and gene therapy research Stamford, CT (PRWEB) April 21, 2015 Alliance for Cancer Gene Therapy
Exclusive Collaboration Includes Option for Astellas to Acquire Potenza TOKYO and CAMBRIDGE, Mass., April 21, 2015 /PRNewswire/ -- Astellas Pharma Inc.
Awards Include $58.5 Million for Five New Large Pragmatic Clinical Studies WASHINGTON, April 21, 2015 /PRNewswire-USNewswire/ -- The Patient-Centered
SEATTLE, April 21, 2015 /PRNewswire/ -- Seattle Children's announced today that 20 of 22 patients treated thus far in a clinical trial using genetically reprogrammed T cells to treat relapsed
MENLO PARK, Calif., April 21, 2015 /PRNewswire/ -- Asterias Biotherapeutics, Inc.
--Data Presented by Donald McDonald, UCSF, at the American Association for Cancer Research Meeting 2015-- SAN FRANCISCO, April 20, 2015 /PRNewswire/ -- SillaJen, Inc., a private clinical-stage
- A serpent whose bite was fabled to produce intense thirst.